BVT Knock-Out ABT/ DE000VC1RDC2 /
08.11.2024 21:43:01 | Изменение+0.140 | Бид22:00:36 | Предложение22:00:36 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.780EUR | +21.88% | - Величина цены спроса: - |
- Величина цены предложения: - |
Abbott Laboratories | 108.73 USD | 31.12.2078 | Call |
GlobeNewswire
06.08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06.06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09.05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25.03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15.03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14.11.2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19.10.2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница